BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31253434)

  • 1. [Role of vitrectomy in suspected vitreous amyloidosis].
    Morice C; Dutheil C; Rougier MB; Delyfer MN; Korobelnik JF; Léger F
    J Fr Ophtalmol; 2019 Dec; 42(10):e463-e464. PubMed ID: 31253434
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 3. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
    Miyahara T; Ohta K; Yamamoto Y; Ueno A; Murata T
    J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of vitreous amyloid formed after liver transplantation.
    Liepnieks JJ; Phan AD; Wise RJ; Hrisomalos FN; Benson MD
    Amyloid; 2016 Jun; 23(2):136-7. PubMed ID: 27043487
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
    Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
    Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients.
    Beirão NM; Matos ME; Meneres MJ; Beirão IM; Costa PP; Torres PA
    Amyloid; 2012 Sep; 19(3):146-51. PubMed ID: 22856884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial vitreous amyloidosis linked with factor V Leiden deficiency.
    Moortgat I; Van Ginderdeuren R; Van Calster J
    Br J Ophthalmol; 2011 Dec; 95(12):1755, 1762. PubMed ID: 20805139
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
    Beirão NM; Matos E; Beirão I; Costa PP; Torres P
    Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent amyloid involvement in the virreous body after vitrectomy.
    Irvine AR; Char DH
    Am J Ophthalmol; 1976 Nov; 82(5):705-8. PubMed ID: 998692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining images of vitreous transthyretin amyloid.
    Latasiewicz M; Adan A; Solé M
    Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
    Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U
    Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical case of the month: non-familial vitreous amyloidosis].
    Tek A; Rakic JM
    Rev Med Liege; 2013; 68(7-8):396-8. PubMed ID: 24053097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
    Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
    Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.
    Koga T; Ando E; Hirata A; Fukushima M; Kimura A; Ando Y; Negi A; Tanihara H
    Am J Ophthalmol; 2003 Feb; 135(2):188-93. PubMed ID: 12566023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual Vitreous Opacity in a Chinese Patient.
    Yu S; Xu Y; Liang X
    JAMA Ophthalmol; 2019 Dec; 137(12):1454-1455. PubMed ID: 31621813
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.
    Kawaji T; Ando Y; Ando E; Nakamura M; Hirata A; Tanihara H
    Amyloid; 2004 Dec; 11(4):257-9. PubMed ID: 15678760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
    Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical demonstration of prealbumin in the vitreous in heredofamilial amyloidosis.
    Doft BH; Rubinow A; Cohen AS
    Am J Ophthalmol; 1984 Mar; 97(3):296-300. PubMed ID: 6702967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.
    Munar-Qués M; Salva-Ladaria L; Mulet-Perera P; Solé M; López-Andreu FR; Saraiva MJ
    Amyloid; 2000 Dec; 7(4):266-9. PubMed ID: 11132095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.